After successful testing in South America, Bacchus Vascular began the U.S. clinical trials for their Deep Vein Thrombosis (DVT) treatment. With 12 hospitals signed up for the trial, they required a comprehensive yet flexible information package to educate physicians and patients about their product. The flexible system of materials addressed uses across all hospitals as well as customized parts for each trial site. The 3-month goal to sign up 40 patients was already reached halfway within the first two weeks.